drugset / Trial / NCT04652661
Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics
RandomizedParallel-groupDouble-blindOther
Summary
An increasing number of studies have reported the use of dexmedetomidine in clinical practice. However, few studies have reported on the intranasal use of dexmedetomidine in radiological procedures The aim of this work is to compare the efficacy and safety of intranasal dexmedetomidine and intranasal midazolam in pediatrics undergoing MRI.
Timeline
- Start
- 2020-12-10
- Primary completion
- 2022-01-01
- Completion
- 2022-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 2 ug/kg | Intranasal |
| Comparator | Midazolam | Small molecule | 0.3 mg/kg | Intranasal |
Indications
No indication recorded.